lamisil terbinafine 250mg (as hydrochloride) tablet
novartis pharmaceuticals australia pty ltd - terbinafine hydrochloride, quantity: 281.25 mg (equivalent: terbinafine, qty 250 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose; colloidal anhydrous silica - treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as trichophyton (eg. t.rubrum, t.mentagrophytes, t.verrucosum, t.violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.
lamisil tablet 250 mg
novartis (singapore) pte ltd - terbinafine hcl eqv terbinafine - tablet, film coated - 250 mg - terbinafine hcl eqv terbinafine 250 mg
lamisil tablets
novartis pharmaceuticals australia pty ltd - terbinafine hydrochloride -
lamisil 250 milligram tablets
b & s healthcare - terbinafine hydrochloride - tablets - 250 milligram - antifungals for systemic use
lamisil 250 milligram tablets
novartis pharmaceuticals uk ltd - terbinafine - tablets - 250 milligram - antifungals for systemic use
lamisil
novartis pharmaceuticals uk limited - terbinafine hydrochloride 250 mg - tablet
lamisil tablets 250mg
novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - terbinafine hydrochloride - tablet - terbinafine hydrochloride 250 mg - antifungals for dermatological use
lamisil 250 mg tablets
novartis ireland limited - terbinafine - tablet - 250 milligram(s) - antifungals for systemic use; terbinafine
lamisil 250mg tablets
novartis pharmaceuticals uk ltd - terbinafine hydrochloride - oral tablet - 250mg
lamisil 250mg tablets
waymade healthcare plc - terbinafine hydrochloride - oral tablet - 250mg